Tongue Squamous Cell Carcinoma Clinical Trial
Official title:
Oncological Outcome of Contralateral Submental Artery Island Flap Versus Primary Closure in Tongue Squamous Cell Carcinoma (Randomize Noninferiority Clinical Trial)
| Verified date | April 2020 |
| Source | Cairo University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to compare the oncological and functional results of the contralateral submental flap with primary closure for reconstruction of tongue squamous cell carcinoma.
| Status | Active, not recruiting |
| Enrollment | 64 |
| Est. completion date | November 2020 |
| Est. primary completion date | October 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - Patient with T1&T2 tongue squamous cell carcinoma. Exclusion Criteria: - Patients with contralateral N positive. - Patients with previous neck surgery that interrupt contralateral facial artery or vein. - Patients with prior radiotherapy to the neck. - Patients with lesions crossing the midline, or those reaching the base of tongue requiring total glossectomy. - Patients second primary tumors at the time of diagnosis. - Patient with recurrent tongue squamous cell carcinoma. |
| Country | Name | City | State |
|---|---|---|---|
| Egypt | Omer M Jamali | Cairo | Faculty Of Dentistry-Cairo University |
| Lead Sponsor | Collaborator |
|---|---|
| Cairo University |
Egypt,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | local recurrence | at least one year post operative |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04333537 -
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
|
Phase 2/Phase 3 |